The total return over the past 12 months is -53.32% vs. +16.94% for the S&P 500. So far it's up -28.87% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (53.32%) | +6.49% | (36.23%) | +10.21% | +7.37% | N/A |
| Total Return CAGR | (53.32%) | +6.49% | (36.23%) | +10.21% | +7.37% | N/A |
| Revenue CAGR | (5.82%) | +17.02% | +13.75% | +29.05% | +39.81% | N/A |
| Net Income CAGR | N/A | N/A | +42.29% | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +80.59% | +70.46% | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +77.01% | +69.10% | N/A | +69.99% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
OptimizeRx Corp. (OPRX)
| Year | Start price | End price | OPRX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $12.26 | $8.72 | (28.87%) | +14.51% | (43.38%) |
| 2025 | $4.86 | $12.26 | +152.26% | +17.72% | +134.54% |
| 2024 | $14.31 | $4.86 | (66.04%) | +24.89% | (90.93%) |
| 2023 | $16.80 | $14.31 | (14.82%) | +26.19% | (41.01%) |
| 2022 | $62.11 | $16.80 | (72.95%) | (18.17%) | (54.78%) |
| 2021 | $31.16 | $62.11 | +99.33% | +28.74% | +70.59% |
| 2020 | $10.27 | $31.16 | +203.41% | +18.37% | +185.04% |
| 2019 | $10.97 | $10.27 | (6.38%) | +31.22% | (37.60%) |
| 2018 | $4.71 | $10.97 | +132.91% | (4.56%) | +137.47% |
| 2017 | $2.43 | $4.71 | +93.83% | +21.70% | +72.13% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
